Carmel Pharma
M├╢lndal, Vastra Gotaland, Sweden
About Carmel Pharma
Carmel Pharma ab engages in the manufacture and distribution of products that improve the quality of life of people who prepare, administer, and dispose of hazardous drugs. It offers the PhaSeal System, a closed-system drug transfer device that prevents hazardous drug interaction with the environment. The company's PhaSeal product is implemented in various cancer centers, oncology practices, and specialty pharmacies in the United States, as well as facilities in Europe and Asia. Carmel Pharma ab was founded in 1994 and is headquartered in Mölndal, Sweden with an additional office in Columbus, Ohio.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 5,001 – 10,000
- Funding stage: M&A
- Last round: Private Equity (May 2009)
- Website: phaseal.com
- Phone: +46 31 703 04 00
Industries & Categories
Biotechnology, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/carmel-pharma-2586351 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.